Todos Medical (TOMDF) Stock Price
Todos Medical Price
Revenue has compounded at 21.6% per year over the past 2 years to 7.70 M USD. Todos Medical's net margin stands at -324.8%, up from -571.8% several years earlier.
Todos Medical stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Todos Medical business model & stock analysis
Frequently asked questions about Todos Medical
The business model of Todos Medical Ltd focuses on providing comprehensive medical solutions, diagnostic tests, and screening services for various health conditions. As a leading healthcare company, Todos Medical aims to identify and develop innovative technologies to improve the detection and management of diseases, including cancer. By offering advanced molecular diagnostic solutions and personalized medicine options, Todos Medical strives to enhance patient outcomes and reduce healthcare costs. With a strong emphasis on cutting-edge research and partnerships with healthcare professionals, the company aims to revolutionize the medical field by offering effective and efficient healthcare solutions.
Todos Medical Ltd is primarily active in the biotech and healthcare industries.
The main competitors of Todos Medical Ltd in the market include companies such as Biocept Inc., Genomic Health Inc., Guardant Health Inc., and Exact Sciences Corporation.
Todos Medical Ltd is a renowned company specializing in medical diagnostics and solutions. Founded in [year], it has emerged as a prominent player in the healthcare industry. Todos Medical Ltd has a rich history of delivering innovative products and services that cater to various medical needs. With a strong focus on research and development, the company has gained recognition for its cutting-edge technologies and reliable diagnostic tools. By continuously expanding its product portfolio and forging strategic partnerships, Todos Medical Ltd has established itself as a trusted name in the market, providing advanced medical solutions worldwide.
Todos Medical Ltd has achieved several significant milestones. The company has successfully developed and commercialized innovative diagnostic solutions, including the proprietary Total Biochemical Infrared Analysis (TBIA) platform. They have made remarkable advancements in cancer screening, with their TBIA-based tests improving detection accuracy and efficiency. Todos Medical has also forged strategic partnerships with leading medical institutions and organizations, expanding their global reach. Additionally, the company has received regulatory approvals for their products, demonstrating their commitment to maintaining high standards in healthcare. These milestones highlight Todos Medical Ltd's dedication to revolutionizing diagnostic capabilities and improving patient outcomes.
Todos Medical Ltd is primarily present in multiple countries and regions worldwide. The company has a global presence, with a focus on several key markets. These include the United States, Israel, Taiwan, and Singapore, amongst others. Todos Medical Ltd strives to expand its reach and market penetration consistently. With a robust international footprint, the company aims to cater to a diverse range of customers and capitalize on emerging business opportunities in different regions. This global presence reinforces Todos Medical Ltd's commitment to delivering innovative solutions and driving growth across various geographical locations.
Todos Medical Ltd represents a set of values and a corporate philosophy centered around innovation, research, and patient care. As a leading biotech company, Todos Medical Ltd is dedicated to delivering advanced diagnostic solutions and personalized medicine to improve healthcare outcomes. With a strong commitment to scientific excellence and technological advancements, the company strives to develop effective and accessible healthcare solutions for different disease areas. By leveraging cutting-edge technologies and collaborations with key industry partners, Todos Medical Ltd is focused on driving innovation and delivering value to patients, healthcare providers, and investors.
Converted at the current exchange rate, the Todos Medical share trades at 0.00 EUR (0.00 USD).
Todos Medical Ltd is a biomedical company specializing in the development and marketing of diagnostic and therapeutic solutions for cancer, viral, and bacterial infections. The company was founded in 2010 and is headquartered in Rehovot, Israel. Todos Medical aims to develop groundbreaking technologies and products that contribute to saving lives and improving the quality of life for patients. The business model of Todos Medical is modular and includes several divisions. A key pillar of the business model is the research and development of new diagnostic and therapeutic products. The company has already achieved significant success in this area, including the development of an innovative blood test that allows for rapid and reliable diagnosis of breast, lung, prostate, and colorectal cancer. Another product development is the TolloTest, a PCR test for the determination of COVID-19 and its variants. In addition to product development, Todos Medical also operates a comprehensive marketing and distribution network. The company works with partner firms in various countries and has established its distribution in North America, Europe, and Asia. Through this collaboration, Todos Medical is able to market and distribute its products worldwide. Another important business area of Todos Medical is clinical research and development. The company conducts its own clinical trials and collaborates with renowned institutions such as the University of California, Los Angeles (UCLA) and the Maryland Proton Treatment Center. The goal of clinical research and development is to gather evidence-based data and insights to demonstrate the effectiveness and safety of Todos Medical products. In addition to commercializing its products and conducting clinical research, Todos Medical also provides a range of service and consulting services. The company offers training and education for medical professionals and supports its customers in implementing its products into clinical practice. In summary, the business model of Todos Medical is characterized by a comprehensive product portfolio, a global distribution network, international clinical research and development, and a wide range of consulting and service offerings. Todos Medical is an innovative company driven by the vision of saving lives and improving people's health. With its groundbreaking technologies and products, the company makes a valuable contribution to cancer diagnostics and therapy, as well as the fight against viral and bacterial infections. Answer: Todos Medical Ltd is a biomedical company specializing in the development and marketing of diagnostic and therapeutic solutions for cancer, viral, and bacterial infections.
The revenue cannot currently be calculated for Todos Medical.
The profit cannot currently be calculated for Todos Medical.
The P/E ratio cannot be calculated for Todos Medical at the moment.
The P/S cannot be calculated for Todos Medical currently.
The Eulerpool Quality Score for Todos Medical is 3/10.
The ISIN of Todos Medical is IL0011392375. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Todos Medical is A2P4UW. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Todos Medical is TOMDF. The ticker symbol is used to trade Todos Medical shares on the stock exchange.
Todos Medical stock
Todos Medical Peer Group
Todos Medical Ticker
Todos Medical FIGI
All fundamentals and in-depth analysis of Todos Medical
Our stock analysis for Todos Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Todos Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.